Video interviews with CARAMBA researchers
MPE's video interviews with CARAMBA researchers Myeloma Patients Europe conducted a series of interviews with CARAMBA researchers on the challenges of CAR T-cell therapy. Watch the videos below, produced by Myeloma Patients Europe. CARAMBA clinical trial updates on...
CARAMBA Meeting Report
The CARAMBA project presents its experiences, lessons learned and achievements in the development of an innovative CAR T-cell therapy for Multiple Myeloma treatment Read more in this meeting report.
The pioneering CARAMBA project is coming to an end
On 30th June 2023, the EU-funded project CARAMBA is coming to an end, marking five years of challenges and successes in the mission to revolutionise multiple myeloma treatment and beyond. The ultimate goal of the CARAMBA project was to develop a new virus-free CAR-T...
6th CARAMBA General Assembly meeting in Frankfurt
On 8th June 2023, the CARAMBA consortium held its 6th and final General Assembly meeting in Frankfurt. Coordinator Prof. Dr. Michael Hudecek provided an overview on the project objectives, success stories, challenges, and future perspectives. The CARAMBA partners...
T-CURX GmbH announces the appointment of Thomas Loeser as CFO
On 15th December, the SME T-CURX GmbH announced the appointment of Thomas Loeser as the new CFO of the company and the attendance of the JPM 41st Annual Healthcare Conference 2023 in San Francisco from Jan 9-12, 2023.Tom has served for more than 20 years as CFO of...
Congratulations to Monica Casucci for receiving her ERC grant
Monica Casucci, group leader of the innovative immunotherapies unit at IRCCS Ospedale San Raffaele, was awarded by the European Research Council, to refine her outstanding research work on a novel CAR specific for the CD44v6 antigen and strategies to improve CAR-T...
Revolutionary Immune Cells: Michael Hudecek receives Schelling-Price for Innovative Cancer Research
This year, the most important scientific price of the BAdW, endowed with 25.000 Euro, was awarded to Michael Hudecek, for his outstanding work on gen-modified CART-T cell therapy for cancer treatment. The Schelling price is awarded bi-annually, for outstanding...
Status and perspective of CART cell therapy trials in Germany
An informative open access article was published on the current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany. As one can tell from the article, the number of clincial trials for CAR-T multiple myeloma therapies is still rather low. While...
Great success of the 5th Digital Myeloma Forum
The 5th digital myeloma forum was a great success. On 9th July, the 5th edition of the Würzburg Myeloma Forum took place. With far more than 200 participants, mostly myeloma patients and their families as well as patient organisations, a large audience learned about...
VJHemOnc interviewing Hermann Einsele
VJHemOnc's video series on CART cells interviewing HErmann Einsele During the EBMT-EHA 4th European CAR T-cell Meeting, VJHemOnc interviewed Hermann Einsele, MD, FRCP, University of Würzburg, Würzburg, Germany on CAR-T therapy for multiple myeloma patients and beyond....
VJHemOnc interviewing Michael Hudecek
VJHemOnc's video series on CART cells interviewing Michael Hudecek During the EBMT-EHA 4th European CAR T-cell Meeting, VJHemOnc interviewed Michael Hudecek, MD, University of Würzburg, Würzburg, Germany on several exciting CAR-T topics. Watch the videos below,...
CARAMBA at the 4th European CART Cell Meeting
CARAMBA AT THE 4th European CART Cell Meeting As in the recent years, CARAMBA was well presented at the 4th European CART Cell Meeting which took place as a fully virtual event this year (10-12 February 2022). The meeting was jointly organised by EHA and EBMT...
CARAMBA publication in Gene Therapy
The CARAMBA Consortium published an article about the CARAMBA project. Within the article you can find information on CART cell technology and on the CARAMBA project. Supplemented by figures, the technology of virus-free gene transfer using the Spleeping Beauty...
White Paper on CAR-T cell therapy development
In 2020, the two EU-projects CARAMBA and EURE-CART jointly organized a regulatory workshop on CAR-T cell development. With the EURE-CART project coming to an end in June 2021, the EURE-CART Consortium has now published a White Paper on CAR-T cell therapy development....
CARAMBA at the 3rd European CAR-T workshop
CARAMBA AT THE 3RD EUROPEAN CAR-T MEETING After two successful European CAR-T meetings in 2019 and 2020, the CARAMBA project took again part in the 3rd European CAR-T workshop (4-6 February 2021), this time virtually due to the current Covid-19 situation. The meeting...
Myeloma Pipeline – MPE publishes clinical trial information sheet
CARAMBA consortium partner Myeloma Patients Europe (MPE) has issued an information sheet about the CARAMBA clinical trial which will take place in four centres of excellence in myeloma clinical care and research: University Hospital Würzburg (Germany), Ospedale San...
REGULATORY WORKSHOP ON THE DEVELOPMENT OF CAR-T CELLS
Jointly organized by the H2020 projects EURE-CART (European Endeavour for Chimeric Antigen Receptor Therapies) & CARAMBA (SLAMF7-CAR T for Immunotherapy of Multiple Myeloma) 29 – 30 January 2020 Meeting ReportEXECUTIVE SUMMARY On 29th and 30th January 2020, the...
Joint regulatory workshop of EURE-CART and CARAMBA
With the first approvals of the CAR T cell treatments in Europe, a partial victory in the fight against hematological malignancies was achieved. However, the route from bench to bedside poses several challenges, demanding for a European-wide harmonization process....
Publication: Genomic Analyses of SLAMF7 CAR-T Cells
In close collarboration between the CARAMBA partners Paul-Ehrlich-Insitiute, DRK-BSD and the University Hospital in Wuerzburg, first CARAMBA data were published on the bioRxiv platform. Genomic Analyses of SLAMF7 CAR-T Cells...
Myeloma Patients Europe webinar on CAR-T cell treatment
With the aim of providing an overview of CAR-T cell treatment in myeloma, healthcare professional expectations and an introduction to some of the advantages and challenges for patients and in bringing it to market, Myeloma Patients Europe (MPE) will held a webinar on...
Myeloma Patients Europe General Assembly
Myeloma Patients Europe held its annual General Assembly on 15-17 March 2019 in Munich, Germany. Next to training, scientific and advocacy sessions, CARAMBA coordinator Dr. Michael Hudecek presented on CAR-T cells in multiple myeloma and AL amyloidosis. Watch here the...
2nd CARAMBA General Assembly in Wuerzburg
On 1st and 2nd April 2019, the CARAMBA General Assembly met for the second time in Wuerzburg to discuss recent results and the next steps towards the clinical trial. All partners enjoyed the friendly and dynamic working atmosphere allowing fruitful discussions and...
CARAMBA Flyer available
Download the CARAMBA_Flyer and share it with your networks!
1st European CAR-T workshop
CARAMBA at the 1st European CAR-T workshop The 1st European CAR-T workshop (14-16 February 2019, Paris) jointly organized by EHA and the EBMT, was co-chaired by the CARAMBA coordinator Dr. Michael Hudecek (Universitaetsklinikum Wuerzburg). Next to the coordinator Dr....
CARAMBA at EHA 2018
CARAMBA was presented by the project coordinator Michael Hudecek at The 23rd European Hematology Association in Stockholm (14-17 June 2018). In the course of an educational and scientific programme highlighting state-of-the-art clinical practice and the latest...
MPE launches Horizon2020 CARAMBA video
Video interview with Michael Hudecek (Universitätsklinikum Würzburg) on CAR-T cell therapy in myeloma At the recent European Haematology Association (EHA) Annual Congress 2018, Myeloma Patients Europe (MPE) and Video Journal of Hematological Oncology...
CARAMBA Kick-off Meeting
The CARAMBA consortium is excited to kick-off the new EU project CARAMBA in Wuerzburg, Germany (12-13th April 2018). Together with its EU officer Katarzyna Stryjniak and its scientific advisor Cameron Turtle, the consortium intensively discussed the new, promising...
Get in touch
You can register here to the CARAMBA newsletter.
